EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering the Anti-Angiogenic Mechanisms of Centella asiatica via Network Pharmacology and Experimental Validation

Bingtian Zhao iD, Yuanyuan Li iD, Binya Wang, Jing Liu, Yang Yang, Qianghua Quan, Quan An, Rong Liang, Chunhuan Liu, Cheng Yang

Molecules · 11.01.2024 · 29 (2) · 362

DOI: 10.3390/molecules29020362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 11.01.2024. Verfasst von Bingtian Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi 21…. Hauptthemen laut MEDLINE: Centella, Triterpenes, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Centella asiatica (CA) has been used to address cancer for centuries in traditional Chinese medicine (TCM). Previous studies demonstrated its anti-angiogenesis efficacy, but the underlying mechanism of its action remains to be further clarified. This study aims to investigate the underlying mechanisms of CA and its triterpenes in anti-angiogenesis for cancer therapeutics through network pharmacology and experimental validation.

Methods

Cytoscape was used to construct a network of compound–disease targets and protein–protein interactions (PPIs) from which core targets were identified. GO and KEGG analyses were performed using Metascape, and the AutoDock-Vina program was used to realize molecular docking for further verification. Then, VEGF165 was employed to establish an induced angiogenesis model. The anti-angiogenic effects of CA were evaluated through assays measuring cell proliferation, migration, and tubular structure formation.

Results

Twenty-five active ingredients in CA had potential targets for anti-angiogenesis including madecassoside, asiaticoside, madecassic acid, asiatic acid, and asiaticoside B. In total, 138 potential targets for CA were identified, with 19 core targets, including STAT3, SRC, MAPK1, and AKT1. A KEGG analysis showed that CA is implicated in cancer-related pathways, specifically PD-1 and AGE-RAGE. Molecular docking verified that the active components of CA have good binding energy with the first four important targets of angiogenesis. In experimental validation, the extracts and triterpenes of CA improved VEGF165-induced angiogenesis by reducing the proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs).

Conclusions

Our results initially demonstrate the effective components and great anti-angiogenic activity of CA. Evidence of the satisfactory anti-angiogenic action of the extracts and triterpenes from CA was verified, suggesting CA’s significant potential as a prospective agent for the therapy of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CentellaTriterpenesNeoplasmsHumansNetwork PharmacologyMolecular Docking SimulationProspective StudiesHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

Centella asiaticaanti-angiogenesiscancernetwork pharmacologytriterpene

Substanzen

Triterpenes

Autor:innen und Institutionen

  • Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, China.
  • Yunnan Baiyao Group Shanghai Science & Technology Co., Ltd., Shanghai 201100, China.
  • East Asia Skin Health Research Center, Beijing 100037, China.

ORCID-Profile: Bingtian Zhao, Yuanyuan Li

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Natural Science Foundation of China

Zitieren

APA

Zhao, B., Li, Y., Wang, B., Liu, J., Yang, Y., Quan, Q., An, Q., Liang, R., Liu, C., & Yang, C. (2024). Uncovering the Anti-Angiogenic Mechanisms of Centella asiatica via Network Pharmacology and Experimental Validation. Molecules, 29(2), 362. https://doi.org/10.3390/molecules29020362

Vancouver

Zhao B, Li Y, Wang B, Liu J, Yang Y, Quan Q, et al. Uncovering the Anti-Angiogenic Mechanisms of Centella asiatica via Network Pharmacology and Experimental Validation. Molecules. 2024;29(2):362. doi:10.3390/molecules29020362

BibTeX
@article{Zhao2024,
  author = {Zhao, Bingtian and Li, Yuanyuan and Wang, Binya and Liu, Jing and Yang, Yang and Quan, Qianghua and An, Quan and Liang, Rong and Liu, Chunhuan and Yang, Cheng},
  title = {Uncovering the Anti-Angiogenic Mechanisms of Centella asiatica via Network Pharmacology and Experimental Validation},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {2},
  pages = {362},
  doi = {10.3390/molecules29020362}
}
Kostenlos starten →